Hypoxic bladder cancers have a poorer outcome following hypofractionated vs conventionally fractionated radiotherapy in the BC2001 and BCON randomised trials
Authors
Smith, Tim A DWest, Catharine M L
Lane, Brian
Irlam-Jones, Joely
More, Elisabet
Mistry, Hitesh
Hoskin, Peter J
Hussain, S. A.
Hall, E.
Porta, N.
Huddart, R. A.
James, N. D.
Choudhury, Ananya
Affiliation
Division of Cancer Sciences, The University of Manchester, Manchester, UKIssue Date
2022
Metadata
Show full item recordCitation
Smith TAD, West CM, Lane B, Irlam-Jones J, More E, Mistry H, et al. Hypoxic bladder cancers have a poorer outcome following hypofractionated vs conventionally fractionated radiotherapy in the BC2001 and BCON randomised trials. Annals of Oncology. 2022 Sep;33(7):S1330-S. PubMed PMID: WOS:000866211602285.Journal
Annals of OncologyDOI
10.1016/j.annonc.2022.07.1812Additional Links
https://dx.doi.org/10.1016/j.annonc.2022.07.1812Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.annonc.2022.07.1812